Titre (en)
Checkpoint
Istex
Racine
Checkpoint
Istex
Exploration
Accueil
Racine
Racine

La maladie de Parkinson en France (serveur d'exploration) - Checkpoint (Istex)

Index « Titre (en) » - entrée « levels »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
level < levels < levocetirizine  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 15.
Ident.Authors (with country if any)Title
000361 (2011) O. Launay ; J. Masurel ; A. Servant-Delmas ; A. Basse-Guérineau ; J. Méritet ; S. Laperche ; P. Sogni [France] ; A. R. RosenbergHigh levels of serum hepatitis B virus DNA in patients with ‘anti‐HBc alone’: role of HBsAg mutants
000389 (2011) V. Mitchell ; G. Robin ; F. Boitrelle [France] ; P. Massart ; C. Marchetti [France] ; F. Marcelli ; J. RigotCorrelation between testicular sperm extraction outcomes and clinical, endocrine and testicular histology parameters in 120 azoospermic men with normal serum FSH levels
000491 (2010) Richard Delorme [France] ; Catalina Betancur [France] ; Pauline Chaste [France] ; Solen Kernéis [France] ; Astrid Stopin [France] ; Marie-Christine Mouren [France] ; Corinne Collet [France] ; Thomas Bourgeron [France] ; Marion Leboyer [France] ; Jean-Marie Launay [France]Reduced 3‐O‐methyl‐dopa levels in OCD patients and their unaffected parents is associated with the low activity M158 COMT allele
000813 (2008) Philippe Chanson ; Françoise Borson-Chazot ; Jean-Marc Kuhn ; Joëlle Blumberg ; Pascal Maisonobe ; Brigitte Delemer [France]Control of IGF‐I levels with titrated dosing of lanreotide Autogel over 48 weeks in patients with acromegaly
000C33 (2004) S. Robelet [France] ; C. Melon [France] ; B. Guillet [France] ; P. Salin [France] ; L. Kerkerian-Le Goff [France]Chronic l‐DOPA treatment increases extracellular glutamate levels and GLT1 expression in the basal ganglia in a rat model of Parkinson's disease
000F14 (2001) Vincent Chieux [France] ; Wassim Chehadeh [France] ; Patrick Hautecoeur [France] ; Jeanne Harvey [États-Unis] ; Pierre Wattré [France] ; Didier Hober [France]Increased levels of antiviral MxA protein in peripheral blood of patients with A chronic disease of unknown etiology
001067 (2000) V. D. Braun [Japon] ; K. P. Huber [Canada] ; M. Vervloet [France] ; C. Amiot [France] ; J. Vergès [France] ; K. Tsukiyama [Japon]The E 2Σ+ → C 2Π Transition of NO and Term Values for the A, D, E, and C Lowest Rydberg Levels
001104 (2000) Marie-Paule Muriel [France] ; Nathalie Lambeng [France] ; Frédéric Darios [France] ; Patrick P. Michel [France] ; Etienne C. Hirsch [France] ; Yves Agid [France] ; Merle Ruberg [France]Mitochondrial free calcium levels (Rhod‐2 fluorescence) and ultrastructural alterations in neuronally differentiated PC12 cells during ceramide‐dependent cell death
001A94 (1994) Jeswinder Sian [Royaume-Uni] ; David T. Dexter [Royaume-Uni] ; Andrew J. Lees [Royaume-Uni] ; Susan Daniel [Royaume-Uni] ; Yves Agid [France] ; France Javoy-Agid [France] ; Peter Jenner [Royaume-Uni] ; C. David Marsden [Royaume-Uni]Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia
001B81 (1993) Aycel Nasr [France] ; Nathalie Bertrand [France] ; Maurice Giroud [France] ; Lucia Septien [France] ; Pierre Gras [France] ; Raymond Dumas [France] ; Alain Beley [France] ; Jean Bralet [France]Cerebrospinal fluid choline levels in Parkinson's disease
001C69 (1992) M. Chritin [France] ; M. Savasta [France] ; F. Mennicken [France] ; A. Bal [France] ; D. N. Abrous [France] ; M. Le Moal [France] ; C. Feuerstein [France] ; J. P. Herman [France]Intrastriatal Dopamine‐rich Implants Reverse the Increase of Dopamine D2 Receptor mRNA Levels Caused by Lesion of the Nigrostriatal Pathway: A Quantitative In Situ Hybridization Study
001E66 (1990) R. Raisman-Vozari [France] ; J.-A. Girault [États-Unis] ; S. Moussaoui [France] ; C. Feuerstein [France] ; P. Jenner [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; Yves Agid [France]Lack of change in striatal DARPP-32 levels following nigrostriatal dopaminergic lesions in animals and in parkinsonian syndromes in man
002111 (1986) Experimental and theoretical autoionisation widths for the 5p P levels of neutral cadmium
002112 (1986) Experimental and theoretical autoionisation widths for the 5p P levels of neutral cadmium
002172 (1985) H. Taquet [France] ; F. Javoy-Agid [France] ; P. Giraud [France] ; J. C. Legrand [France] ; Yves Agid [France] ; F. Cesselin [France]Dynorphin levels in parkinsonian patients: Leu5-enkephalin production from either proenkephalin A or prodynorphin in human brain

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Istex/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Title.i -k "levels" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Title.i  \
                -Sk "levels" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Istex
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Title.i
   |clé=    levels
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024